56181-82-9 Usage
Description
3-(4'-Bromo[1,1'-biphenyl]-4-yl)-1,2,3,4-tetrahydro-1-naphthalenol is a complex organic compound with a unique molecular structure that features a naphthalenol core and a biphenyl group with a bromine atom. 3-(4'-Bromo[1,1'-biphenyl]-4-yl)-1,2,3,4-tetrahydro-1-naphthalenol is known for its potential applications in the synthesis of various pharmaceutical agents and chemical products.
Uses
Used in Pharmaceutical Industry:
3-(4'-Bromo[1,1'-biphenyl]-4-yl)-1,2,3,4-tetrahydro-1-naphthalenol is used as a key intermediate in the preparation of 4-hydroxycoumarin derivatives, which possess antitumor activities. These derivatives are valuable in the development of anticancer drugs, targeting various types of cancer cells and offering potential therapeutic benefits.
Used in Pest Control Industry:
3-(4'-Bromo[1,1'-biphenyl]-4-yl)-1,2,3,4-tetrahydro-1-naphthalenol is also utilized in the synthesis of diphenacoum and brodifacoum (B677900), which are potent rodenticides. These compounds are effective in controlling rodent populations, providing a solution for pest management in various settings, including agriculture, residential, and commercial areas.
Check Digit Verification of cas no
The CAS Registry Mumber 56181-82-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,1,8 and 1 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 56181-82:
(7*5)+(6*6)+(5*1)+(4*8)+(3*1)+(2*8)+(1*2)=129
129 % 10 = 9
So 56181-82-9 is a valid CAS Registry Number.
56181-82-9Relevant articles and documents
Synthesis and antitumor activity of 4-hydroxycoumarin derivatives
Jung, Jae-Chul,Lee, Ji-Ho,Oh, Seikwan,Lee, Jae-Gon,Park, Oee-Sook
, p. 5527 - 5531 (2007/10/03)
A series of 4-hydroxycoumarin derivatives was prepared and evaluated for antitumor activity against five human tumor cell lines. A series of 4-hydroxycoumarin derivatives was prepared and evaluated for antitumor activity. The key fragments were 2a-c, 5c, 12b, 13b, 17, and 18 which were prepared via dianion ring cyclization, Friedel-Crafts acylation, and Reformatsky reaction. Compound 20b showed the most potent antitumor activity among the total 12 derivatives and compounds 19a and 19b exhibited efficacy comparable to etoposide in vitro antitumor activity.